Biovation's Acquisition

Biovation was acquired by Merck KGaA on October 27, 2000.

Biovation focuses on proprietary technologies that eliminate immunogenicity in antibodies and other proteins in order to develop biotherapeutic drugs with a superior safety profile. Biovation's techno…

Articles about Biovation's Acquisition: